Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Overview of attention for article published in Stroke, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 41 X users

facebook: 1 Facebook page

Readers on

mendeley: 53 Mendeley

So far, Altmetric has seen 47 X posts from 41 X users, with an upper bound of 148,313 followers.

RT @nadinethepharmd: Timely post by @StrokeAHA_ASA to kick off #strokemonth as we go live with our formulary conversion from alteplase to t…

#CPPPLU Highlights: Updated SRMA in @StrokeAHA_ASA found comparable sICH complication rates between pts treated w/ tenecteplase vs alteplase for AIS. Rate of sICH may be ⬆️in those w/ higher (≥0.4 mg/kg) tenecteplase vs standard doses. #PharmICU https://…

RT @StrokeAHA_ASA: #CME available for #Stroke article "Complications of Intravenous Tenecteplase Versus Alteplase for the Treatment of Acut…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 43 additional X posts.